Ingenol disoxate

DB15109InvestigationalSmall molecule

Ingenol disoxate is under investigation in clinical trial NCT02120456 (Safety and Efficacy of Escalating Doses of LEO 43204 Applied Once Daily for Two Consecutive Days on Approximately 250 cm2 on...

Formula / weight: C₂₈H₃₇NO₇ · 499.604 g/mol (avg)
Code names: LEO 43204

Resolves to

Compound

UNII3B100VJ4ZWCAS1383547-60-1ChEMBLCHEMBL3989918

Structure

InChIKeyGLIUZQUNUNICGS-XUBYYPQFSA-NSMILESCCC1=C(C(=O)O[C@H]2C(C)=C[C@@]34[C@H](C)C[C@@H]5[C@H]([C@H](C=C(CO)[C@@H](O)[C@]23O)C4=O)C5(C)C)C(CC)=NO1

What you can answer from here — as of April 23, 2025

6Clinical trialsPhase, status and sponsor resolved per trial

Which companies are running trials of Ingenol disoxate, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account